SHFH · Scientist Home Future Health Ltd
$8.00
+0.10 (+1.27%)
At close · Aug 28
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“For the six months ended June 30, 2026, the Company incurred a net loss of $199,924 and net current liabilities of $214,975. These factors raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued.”View the 10-Q filed Aug 11, 2026
Market Cap
$189.73M
Shares
23.72M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$204.06K
FY2025
Net Income
-$231.73K
FY2025
Gross Margin
40.13%
FY2025
Operating Margin
-113.56%
FY2025
Diluted EPS
-$0.01
FY2025
Operating Cash Flow
-$248.28K
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 |
|---|---|---|
| $399.31K | $204.06K | |
| $263.9K | $122.17K | |
| $136.84K | $81.89K | |
| — | 40.13% | |
| $537.33K | $313.61K | |
| -$537.33K | -$313.61K | |
| -$400.5K | -$231.73K | |
| — | -113.56% | |
| -$400.5K | -$231.73K | |
| $0 | $0 | |
| -$400.5K | -$231.73K | |
| — | -113.56% | |
| -$403.36K | -$234.59K | |
| USD/shares | -$0.01 | -$0.01 |
| shares | — | 23.59M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 |
|---|---|
| Retail Trading Business B | $197,447 |
| Service Business | $6,608 |
By Geography (USD)
| Component | FY2025 |
|---|---|
| Non Hong Kong | $0 |
By Product & Service (USD)
| Component | FY2025 |
|---|---|
| Scientist Home Mixed Gelatine Hydrolysate | $60,451 |
| Others Delivery Fee | $47,810 |
| Scientist Home High Concentration Proteinase | $43,752 |
| Scientist Home Vein Cream | $22,630 |
| Scientist Home Cholipolysis Cholic Acid | $13,386 |
| Scientist Home Bone Gelatine Hydrolysate | $9,418 |